Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade
Sahil Sahni(National Institutes of Health), Eytan Ruppin(National Institutes of Health), Matthew Nagy(National Institutes of Health), Ingrid Ferreira(Wellcome Sanger Institute), Binbin Wang(National Institutes of Health), Kun Wang(Guangdong General Hospital), Di Wu(National Institutes of Health), Saugato Rahman Dhruba(National Institutes of Health), Sushant Patkar(National Institutes of Health)
Cited by 2
Related Papers
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis
|Experimental & Molecular Medicine|2022|321
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
|Nature Communications|2020|156
Mechanosensitive Ion Channel Piezo1 Activated by Matrix Stiffness Regulates Oxidative Stress‐Induced Senescence and Apoptosis in Human Intervertebral Disc Degeneration
|Oxidative Medicine and Cellular Longevity|2021|126